Bernhardt G. Zeiher

Insider Reports History

Location
Entrada Therapeutics, Inc., 6 Tide Street, Boston, MA
Signature
/s/ Jared Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bernhardt G. Zeiher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ABEONA THERAPEUTICS INC. Director Common Stock 47.1K $254K $5.38 Jan 31, 2025 Direct
Amylyx Pharmaceuticals, Inc. Director Common Stock 10K $37K $3.70 Mar 20, 2025 Direct
Amylyx Pharmaceuticals, Inc. Director Stock Option (right to buy) 25K Jun 5, 2025 Direct
Entrada Therapeutics, Inc. Director Stock Option (Right to Buy) 19K Jun 11, 2025 Direct

Insider Reports Filed by Bernhardt G. Zeiher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRDA Entrada Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 12, 2025 Director
AMLX Amylyx Pharmaceuticals, Inc. Jun 5, 2025 1 $0 4 Jun 9, 2025 Director
AMLX Amylyx Pharmaceuticals, Inc. Mar 20, 2025 1 $37K 4 Mar 24, 2025 Director
ABEO ABEONA THERAPEUTICS INC. Jan 31, 2025 1 $0 4 Feb 3, 2025 Director
ABEO ABEONA THERAPEUTICS INC. Aug 13, 2024 1 $0 4 Aug 14, 2024 Director
ABEO ABEONA THERAPEUTICS INC. Aug 8, 2024 0 $0 3 Aug 14, 2024 Director
TRDA Entrada Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Mar 14, 2024 1 $0 4 Mar 15, 2024 Director
AMLX Amylyx Pharmaceuticals, Inc. Mar 14, 2024 0 $0 3 Mar 15, 2024 Director
TRDA Entrada Therapeutics, Inc. Apr 4, 2023 1 $0 4 Apr 4, 2023 Director
TRDA Entrada Therapeutics, Inc. Apr 4, 2023 0 $0 3 Apr 4, 2023 Director